Health
FDA Approval Helps Immunocompromised Shingles Sufferers – Infection Control Today
Shingrix was originally approved by the FDA in 2017 for the prevention of shingles in adults 50 years and older. Now, it’s approved…
Adults aged 18 years and older with increased risk of immunodeficiency or immunosuppression have been given another means to fight the disease thanks to the approval by the US Food and Drug Administration (FDA) of the non-live, recombinant sub-unit adjuvanted…
Continue Reading
-
Business17 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Business13 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business9 hours agoDicker Data rides the AI trend to double digit growth
-
Business12 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy